(+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of KCNMA1 mRNA CTD PMID:18695509 (+)-Pimaric acid affects response to substance EXP 6480464 KCNMA1 mRNA affects the susceptibility to pimaric acid CTD PMID:19247476 (R)-noradrenaline affects response to substance EXP 6480464 KCNMA1 protein affects the susceptibility to Norepinephrine CTD PMID:22226998 1,2-dichloroethane increases expression ISO RGD:731982 6480464 ethylene dichloride results in increased expression of KCNMA1 mRNA CTD PMID:28189721 , PMID:28960355 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of KCNMA1 mRNA CTD PMID:17557909 17beta-estradiol increases activity ISO RGD:731981 6480464 Estradiol results in increased activity of KCNMA1 protein CTD PMID:18068743 17beta-estradiol multiple interactions EXP 6480464 Fulvestrant inhibits the reaction [Estradiol results in decreased expression of KCNMA1 mRNA alternative form] more ... CTD PMID:16102753 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of KCNMA1 mRNA more ... CTD PMID:16102753 17beta-estradiol multiple interactions ISO RGD:731981 6480464 [Estradiol co-treated with Progesterone] results in increased expression of KCNMA1 mRNA more ... CTD PMID:18068743 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:731981 6480464 Dihydrotestosterone results in increased expression of KCNMA1 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:731982 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:731982 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-methylcholine affects expression ISO RGD:731981 6480464 beta-methylcholine affects the expression of KCNMA1 mRNA CTD PMID:21179406 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:731982 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 mRNA, [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 protein CTD PMID:27605626 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731982 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 mRNA, [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 protein CTD PMID:27605626 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731981 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of KCNMA1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:731982 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of KCNMA1 mRNA CTD PMID:31881267 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of KCNMA1 mRNA CTD PMID:24780913 acetylcholine affects response to substance EXP 6480464 KCNMA1 protein affects the susceptibility to Acetylcholine CTD PMID:22226998 aflatoxin B1 increases expression ISO RGD:731982 6480464 Aflatoxin B1 results in increased expression of KCNMA1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:731981 6480464 Aflatoxin B1 results in decreased methylation of KCNMA1 exon CTD PMID:30157460 aflatoxin B1 affects methylation ISO RGD:731981 6480464 Aflatoxin B1 affects the methylation of KCNMA1 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:731981 6480464 Aflatoxin B1 results in decreased expression of KCNMA1 mRNA CTD PMID:31555880 , PMID:32234424 Aflatoxin B2 alpha affects methylation ISO RGD:731981 6480464 aflatoxin B2 affects the methylation of KCNMA1 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO RGD:731981 6480464 Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein] more ... CTD PMID:21413024 all-trans-retinoic acid decreases expression ISO RGD:731981 6480464 Tretinoin results in decreased expression of KCNMA1 mRNA CTD PMID:23724009 amiodarone increases expression ISO RGD:731981 6480464 Amiodarone results in increased expression of KCNMA1 mRNA CTD PMID:19774075 aristolochic acid decreases expression ISO RGD:731981 6480464 aristolochic acid I results in decreased expression of KCNMA1 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:731981 6480464 Arsenic affects the methylation of KCNMA1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:731981 6480464 Arsenic affects the methylation of KCNMA1 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:731981 6480464 Arsenic Trioxide results in increased expression of KCNMA1 mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO RGD:731981 6480464 Benzo(a)pyrene results in decreased expression of KCNMA1 mRNA CTD PMID:20064835 more ... benzo[a]pyrene affects methylation ISO RGD:731981 6480464 Benzo(a)pyrene affects the methylation of KCNMA1 intron, Benzo(a)pyrene affects the methylation of KCNMA1 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:731982 6480464 Benzo(a)pyrene results in decreased methylation of KCNMA1 intron CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:731981 6480464 Benzo(a)pyrene results in increased methylation of KCNMA1 3' UTR, Benzo(a)pyrene results in increased methylation of KCNMA1 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:731982 6480464 Benzo(a)pyrene results in increased expression of KCNMA1 mRNA CTD PMID:22228805 benzo[e]pyrene affects methylation ISO RGD:731981 6480464 benzo(e)pyrene affects the methylation of KCNMA1 intron CTD PMID:30157460 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of KCNMA1 mRNA CTD PMID:17630414 bis(2-chloroethyl) sulfide decreases expression ISO RGD:731981 6480464 Mustard Gas results in decreased expression of KCNMA1 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of KCNMA1 mRNA CTD PMID:20920545 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731981 6480464 Diethylhexyl Phthalate results in increased expression of KCNMA1 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of KCNMA1 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A decreases methylation ISO RGD:731981 6480464 bisphenol A results in decreased methylation of KCNMA1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:731981 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of KCNMA1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:731982 6480464 bisphenol A results in decreased expression of KCNMA1 mRNA CTD PMID:31250031 bisphenol A multiple interactions ISO RGD:731982 6480464 ESR2 protein affects the reaction [bisphenol A results in decreased expression of KCNMA1 mRNA] CTD PMID:31250031 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of KCNMA1 gene CTD PMID:28505145 buta-1,3-diene decreases expression ISO RGD:731982 6480464 1, 3-butadiene results in decreased expression of KCNMA1 mRNA CTD PMID:29038090 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of KCNMA1 promoter CTD PMID:22457795 caesium atom affects activity ISO RGD:731982 6480464 Cesium affects the activity of KCNMA1 protein CTD PMID:16636204 calcium atom increases response to substance EXP 6480464 KCNMA1 mRNA alternative form results in increased susceptibility to Calcium CTD PMID:28090300 calcium atom increases response to substance ISO RGD:731981 6480464 KCNMA1 mRNA alternative form results in increased susceptibility to Calcium CTD PMID:28090300 calcium atom multiple interactions ISO RGD:731981 6480464 [KCNMB1 protein co-treated with KCNMA1 protein] results in increased transport of Calcium, Lithocholic Acid promotes the reaction [[KCNMB1 protein co-treated with KCNMA1 protein] results in increased transport of Calcium] CTD PMID:22123969 calcium(0) multiple interactions ISO RGD:731981 6480464 [KCNMB1 protein co-treated with KCNMA1 protein] results in increased transport of Calcium, Lithocholic Acid promotes the reaction [[KCNMB1 protein co-treated with KCNMA1 protein] results in increased transport of Calcium] CTD PMID:22123969 calcium(0) increases response to substance EXP 6480464 KCNMA1 mRNA alternative form results in increased susceptibility to Calcium CTD PMID:28090300 calcium(0) increases response to substance ISO RGD:731981 6480464 KCNMA1 mRNA alternative form results in increased susceptibility to Calcium CTD PMID:28090300 chlordecone affects expression ISO RGD:731982 6480464 Chlordecone affects the expression of KCNMA1 mRNA CTD PMID:33711761 cisplatin multiple interactions ISO RGD:731981 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of KCNMA1 mRNA more ... CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:731981 6480464 Cisplatin results in decreased expression of KCNMA1 mRNA CTD PMID:19561079 , PMID:27392435 clothianidin decreases expression ISO RGD:731981 6480464 clothianidin results in decreased expression of KCNMA1 mRNA CTD PMID:31626844 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of KCNMA1 mRNA CTD PMID:26033743 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of KCNMA1 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of KCNMA1 mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in increased expression of KCNMA1 mRNA CTD PMID:26033743 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of KCNMA1 mRNA CTD PMID:26577399 D-glucose multiple interactions ISO RGD:731981 6480464 Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein] more ... CTD PMID:21413024 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of KCNMA1 mRNA CTD PMID:23914054 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [nitrofen results in decreased expression of KCNMA1 mRNA], Dexamethasone inhibits the reaction [nitrofen results in decreased expression of KCNMA1 protein] CTD PMID:15088113 dexamethasone multiple interactions ISO RGD:731981 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of KCNMA1 mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:731982 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 mRNA, [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 protein CTD PMID:27605626 diarsenic trioxide increases expression ISO RGD:731981 6480464 Arsenic Trioxide results in increased expression of KCNMA1 mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:731982 6480464 Dibutyl Phthalate results in decreased expression of KCNMA1 mRNA CTD PMID:21266533 dioxygen decreases response to substance EXP 6480464 KCNMA1 mRNA alternative form results in decreased susceptibility to Oxygen deficiency CTD PMID:28090300 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of KCNMA1 mRNA alternative form, Oxygen deficiency results in increased expression of KCNMA1 protein alternative form CTD PMID:28090300 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of KCNMA1 mRNA CTD PMID:29391264 endosulfan decreases expression ISO RGD:731981 6480464 Endosulfan results in decreased expression of KCNMA1 mRNA CTD PMID:30090376 ethanol increases activity ISO RGD:731982 6480464 Ethanol results in increased activity of KCNMA1 protein CTD PMID:16626657 ethanol increases expression ISO RGD:731982 6480464 Ethanol results in increased expression of KCNMA1 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:731982 6480464 Ethanol affects the splicing of KCNMA1 mRNA CTD PMID:30319688 folic acid decreases expression ISO RGD:731982 6480464 Folic Acid results in decreased expression of KCNMA1 mRNA CTD PMID:25629700 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of KCNMA1 protein CTD PMID:30974163 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [Estradiol results in decreased expression of KCNMA1 mRNA alternative form] more ... CTD PMID:16102753 fulvestrant multiple interactions ISO RGD:731981 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of KCNMA1 gene CTD PMID:31601247 fulvestrant increases methylation ISO RGD:731981 6480464 Fulvestrant results in increased methylation of KCNMA1 gene CTD PMID:31601247 genistein increases expression ISO RGD:731982 6480464 Genistein results in increased expression of KCNMA1 mRNA CTD PMID:32186404 glucose multiple interactions ISO RGD:731981 6480464 Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein] more ... CTD PMID:21413024 hydrogen peroxide affects response to substance EXP 6480464 KCNMA1 mRNA affects the susceptibility to Hydrogen Peroxide CTD PMID:19247476 indometacin multiple interactions ISO RGD:731982 6480464 [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 mRNA, [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Indomethacin co-treated with rosiglitazone co-treated with Triiodothyronine] results in increased expression of KCNMA1 protein CTD PMID:27605626 indometacin multiple interactions ISO RGD:731981 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of KCNMA1 mRNA CTD PMID:28628672 Lasiocarpine decreases expression ISO RGD:731981 6480464 lasiocarpine results in decreased expression of KCNMA1 mRNA CTD PMID:32234424 lithocholic acid multiple interactions ISO RGD:731981 6480464 [KCNMB1 protein co-treated with KCNMA1 protein] results in increased susceptibility to Lithocholic Acid more ... CTD PMID:22123969 lithocholic acid increases response to substance ISO RGD:731981 6480464 KCNMA1 mRNA alternative form results in increased susceptibility to Lithocholic Acid CTD PMID:28090300 lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid analog results in increased activity of [KCNMB1 protein co-treated with KCNMA1 protein], Lithocholic Acid results in increased activity of [KCNMB1 protein co-treated with KCNMA1 protein] CTD PMID:18650555 lithocholic acid increases response to substance EXP 6480464 KCNMA1 mRNA alternative form results in increased susceptibility to Lithocholic Acid, KCNMA1 protein results in increased susceptibility to Lithocholic Acid CTD PMID:18242174 , PMID:28090300 maneb multiple interactions ISO RGD:731982 6480464 [Paraquat co-treated with Maneb] affects the expression of KCNMA1 mRNA CTD PMID:22563483 methapyrilene decreases expression ISO RGD:731981 6480464 Methapyrilene results in decreased expression of KCNMA1 mRNA CTD PMID:31555880 methapyrilene affects methylation ISO RGD:731981 6480464 Methapyrilene affects the methylation of KCNMA1 intron CTD PMID:30157460 methotrexate increases expression ISO RGD:731981 6480464 Methotrexate results in increased expression of KCNMA1 mRNA CTD PMID:24449571 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of KCNMA1 gene CTD PMID:23303685 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of KCNMA1 mRNA CTD PMID:25972201 N-Nitrosopyrrolidine decreases expression ISO RGD:731981 6480464 N-Nitrosopyrrolidine results in decreased expression of KCNMA1 mRNA CTD PMID:32234424 nickel atom multiple interactions ISO RGD:731981 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of KCNMA1 mRNA] CTD PMID:14575637 nickel atom decreases expression ISO RGD:731981 6480464 Nickel results in decreased expression of KCNMA1 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom affects expression ISO RGD:731981 6480464 Nickel affects the expression of KCNMA1 mRNA CTD PMID:14575637 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of KCNMA1 mRNA, nitrofen results in decreased expression of KCNMA1 protein CTD PMID:15088113 , PMID:33484710 nitrofen multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [nitrofen results in decreased expression of KCNMA1 mRNA], Dexamethasone inhibits the reaction [nitrofen results in decreased expression of KCNMA1 protein] CTD PMID:15088113 NS 1619 multiple interactions ISO RGD:731981 6480464 NS 1619 binds to and results in increased activity of KCNMA1 protein more ... CTD PMID:21413024 O-methyleugenol decreases expression ISO RGD:731981 6480464 methyleugenol results in decreased expression of KCNMA1 mRNA CTD PMID:32234424 paclitaxel affects response to substance ISO RGD:731981 6480464 KCNMA1 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paraquat multiple interactions ISO RGD:731982 6480464 [Paraquat co-treated with Maneb] affects the expression of KCNMA1 mRNA CTD PMID:22563483 paraquat increases expression ISO RGD:731982 6480464 Paraquat results in increased expression of KCNMA1 mRNA CTD PMID:22563483 Paxilline affects response to substance EXP 6480464 KCNMA1 protein affects the susceptibility to paxilline CTD PMID:22226998 PCB138 multiple interactions ISO RGD:731982 6480464 [2 more ... CTD PMID:25510870 pentanal increases expression ISO RGD:731981 6480464 pentanal results in increased expression of KCNMA1 mRNA CTD PMID:26079696 pergolide decreases activity EXP 6480464 Pergolide results in decreased activity of KCNMA1 protein CTD PMID:16129789 phloretin affects response to substance EXP 6480464 KCNMA1 mRNA affects the susceptibility to Phloretin CTD PMID:19247476 piroxicam multiple interactions ISO RGD:731981 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of KCNMA1 mRNA CTD PMID:21858171 potassium atom increases transport ISO RGD:731982 6480464 KCNMA1 protein results in increased transport of Potassium CTD PMID:16020453 potassium atom affects transport EXP 6480464 KCNMA1 protein affects the transport of Potassium CTD PMID:22226998 progesterone multiple interactions ISO RGD:731981 6480464 [Estradiol co-treated with Progesterone] results in increased expression of KCNMA1 mRNA, Progesterone inhibits the reaction [Estradiol results in increased activity of KCNMA1 protein] CTD PMID:18068743 , PMID:20660070 progesterone increases expression ISO RGD:731981 6480464 Progesterone results in increased expression of KCNMA1 mRNA, Progesterone results in increased expression of KCNMA1 protein CTD PMID:21795739 progesterone decreases activity ISO RGD:731981 6480464 Progesterone results in decreased activity of KCNMA1 protein CTD PMID:18068743 progesterone increases expression EXP 6480464 Progesterone results in increased expression of KCNMA1 mRNA, Progesterone results in increased expression of KCNMA1 mRNA alternative form CTD PMID:16102753 propanal increases expression ISO RGD:731981 6480464 propionaldehyde results in increased expression of KCNMA1 mRNA CTD PMID:26079696 pyridaben increases expression ISO RGD:731982 6480464 pyridaben results in increased expression of KCNMA1 mRNA CTD PMID:22563483 rubidium atom affects activity ISO RGD:731982 6480464 Rubidium affects the activity of KCNMA1 protein CTD PMID:16636204 silicon dioxide increases expression ISO RGD:731981 6480464 Silicon Dioxide analog results in increased expression of KCNMA1 mRNA CTD PMID:25895662 sodium arsenite affects methylation ISO RGD:731981 6480464 sodium arsenite affects the methylation of KCNMA1 gene CTD PMID:28589171 sodium arsenite decreases expression ISO RGD:731981 6480464 sodium arsenite results in decreased expression of KCNMA1 mRNA CTD PMID:29301061 T-2 toxin increases expression ISO RGD:731981 6480464 T-2 Toxin results in increased expression of KCNMA1 mRNA CTD PMID:31863870 tamoxifen multiple interactions ISO RGD:731981 6480464 Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]], Tamoxifen inhibits the reaction [Glucose results in decreased activity of [KCNMA1 protein binds to KCNMB1 protein]] CTD PMID:21413024 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of KCNMA1 mRNA CTD PMID:17630414 temozolomide decreases expression ISO RGD:731981 6480464 Temozolomide results in decreased expression of KCNMA1 mRNA CTD PMID:31758290 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of KCNMA1 mRNA, Carbon Tetrachloride results in increased expression of KCNMA1 protein CTD PMID:16644059 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of KCNMA1 mRNA CTD PMID:31150632 tetraethylammonium multiple interactions ISO RGD:731981 6480464 Tetraethylammonium inhibits the reaction [Estradiol results in increased activity of KCNMA1 protein] more ... CTD PMID:18068743 , PMID:21413024 thallium affects activity ISO RGD:731982 6480464 Thallium affects the activity of KCNMA1 protein CTD PMID:16636204 toluene decreases activity ISO RGD:731982 6480464 Toluene results in decreased activity of KCNMA1 protein CTD PMID:16626657 topotecan affects response to substance ISO RGD:731981 6480464 KCNMA1 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of KCNMA1 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:731981 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of KCNMA1 mRNA] CTD PMID:14575637 trichostatin A decreases expression ISO RGD:731981 6480464 trichostatin A results in decreased expression of KCNMA1 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:731982 6480464 Valproic Acid affects the expression of KCNMA1 mRNA CTD PMID:17292431 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of KCNMA1 mRNA CTD PMID:29427782 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of KCNMA1 mRNA CTD PMID:19015723 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of KCNMA1 gene CTD PMID:31682807 XL147 multiple interactions ISO RGD:731982 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNMA1 mRNA CTD PMID:27935865
